Jazz Pharmaceuticals plc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Jazz Pharmaceuticals plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Jazz Pharmaceuticals plc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $312M, a 33.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $312M +$77.6M +33.1% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $235M +$80.5M +52.2% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $154M +$76.9M +99.4% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $77.3M +$11M +16.6% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $66.3M +$5.07M +8.28% Dec 31, 2019 10-K 2021-02-23
Q4 2018 $61.2M +$9.09M +17.4% Dec 31, 2018 10-K 2020-02-25
Q4 2017 $52.1M -$1.04M -1.96% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $53.2M +$19.2M +56.7% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $33.9M +$4.25M +14.3% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $29.7M +$9.01M +43.5% Dec 31, 2014 10-K 2016-02-23
Q4 2013 $20.7M +$3.22M +18.4% Dec 31, 2013 10-K 2015-02-24
Q4 2012 $17.5M -$93.7M -84.3% Dec 31, 2012 10-K 2014-02-25
Q4 2011 $111M -$44.3M -28.5% Dec 31, 2011 10-K 2013-02-26
Q4 2010 $156M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.